Oneness Biotech Co (ROCO:4743) PE Ratio: 384.62 (As of Aug. 23, 2026) — 27% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4743 Oneness Biotech Co Ltd ROCO:4743
57 GF Score
Price NT$50.00
GF Value NT$103.71
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Oneness Biotech Co PE Ratio?

Oneness Biotech Co ROCO:4743 +3.52% 57 PE Ratio is 384.62 as of Aug. 23, 2026, which is 27% above its 10-year median of 303.42. GuruFocus rates ROCO:4743 with a GF Score™ of 57/100 and a GF Value™ of NT$103.71 (Possible Value Trap). The stock has 3 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-23), Oneness Biotech Co's share price is NT$50.00. Oneness Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.13. Therefore, Oneness Biotech Co's PE Ratio for today is 384.62.

During the past 13 years, Oneness Biotech Co's highest PE Ratio was 3837.53. The lowest was 74.00. And the median was 303.42.

Oneness Biotech Co's EPS (Diluted) for the three months ended in Jun. 2026 was NT$0.52. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.13.

As of today (2026-08-23), Oneness Biotech Co's share price is NT$50.00. Oneness Biotech Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.12. Therefore, Oneness Biotech Co's PE Ratio without NRI ratio for today is 406.50.

During the past 13 years, Oneness Biotech Co's highest PE Ratio without NRI was 3837.53. The lowest was 74.00. And the median was 303.42.

Oneness Biotech Co's EPS without NRI for the three months ended in Jun. 2026 was NT$0.52. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.12.

During the past 13 years, Oneness Biotech Co's highest 3-Year average EPS without NRI Growth Rate was 117.10% per year. The lowest was -164.00% per year. And the median was -33.90% per year.

Oneness Biotech Co's EPS (Basic) for the three months ended in Jun. 2026 was NT$0.52. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.13.

Back to Basics: PE Ratio


Oneness Biotech Co  (ROCO:4743) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Oneness Biotech Co PE Ratio Related Terms


Oneness Biotech Co PE Ratio Historical Data

* Premium members only.

The historical data trend for Oneness Biotech Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oneness Biotech Co PE Ratio Chart

Oneness Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss 268.57 At Loss At Loss At Loss

Oneness Biotech Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss 401.54

ROCO:4743 vs VRTX, REGN, RVMD: PE Ratio Comparison

For the Biotechnology subindustry, Oneness Biotech Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oneness Biotech Co PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's PE Ratio falls into.


ROCO:4743
57GF Score
Oneness Biotech Co Ltd ROCO:4743
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oneness Biotech Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Oneness Biotech Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=50.00/0.130
=384.62

Oneness Biotech Co's Share Price of today is NT$50.00.
Oneness Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.13.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 384.62 mean?
Oneness Biotech Co (ROCO:4743) has a PE Ratio of 384.62 as of Aug. 23, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Oneness Biotech Co and its competitors. This is 27% above median its historical median of 303.42. Over the past decade, Oneness Biotech Co's PE Ratio has ranged from 74.00 to 3,837.53.
Is Oneness Biotech Co's PE Ratio too high?
Oneness Biotech Co's current PE Ratio of 384.62 is 27% above median its 10-year median of 303.42. Over the past 10 years, this metric has ranged from a low of 74.00 to a high of 3,837.53. Overall, Oneness Biotech Co has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneness Biotech Co's PE Ratio compare to VRTX and REGN?
Oneness Biotech Co's PE Ratio of 384.62 can be compared against companies in the Biotechnology industry. Historically, Oneness Biotech Co's own PE Ratio has ranged from 74.00 to 3,837.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Biotechnology company?
A good PE Ratio depends on the Biotechnology industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Oneness Biotech Co and its competitors. Oneness Biotech Co's current PE Ratio is 384.62, which is 27% above median its own 10-year median of 303.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneness Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Oneness Biotech Co (ROCO:4743) is currently considered Possible Value Trap. The stock's GF Value™ is NT$103.71, compared to a current price of NT$50.00 — trading 51.8% below its estimated fair value. The current PE Ratio is 384.62, which is 27% above median its 10-year median of 303.42. Oneness Biotech Co's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Oneness Biotech Co (ROCO:4743), the current PE Ratio is 384.62 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oneness Biotech Co (ROCO:4743) Overvalued in 2026?

Based on GuruFocus' analysis, Oneness Biotech Co stock appears to be undervalued. The current stock price of NT$50.00 is trading 51.8% below its estimated GF Value™ of NT$103.71. GuruFocus considers Oneness Biotech Co to be Possible Value Trap.

Key valuation signals for ROCO:4743:

  • PE Ratio: 384.62 (27% above median its 10-year median of 303.42)
  • GF Value™: NT$103.71 vs. price of NT$50.00 (51.8% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oneness Biotech Co Business Description

Address Zhongxiao West Road, No. 66, 35th Floor, Section 1, Zhongzheng District, Taipei, TWN, 100
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The Group's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and Bonvadis, a wound care medical device. It also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, SNS851, and others. The Group operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation and organic food segment.
57GF Score

Get the complete analysis for ROCO:4743

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.00
Price
NT$103.71
GF Value